Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl compounds as IRAK inhibitors and uses thereof

Heteroaryl compounds as IRAK inhibitors and uses thereof

US Patent 9969710 · Granted May 15, 2018

Estimated economic value: $97,235,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscarinic acetylcholine M1 receptor antagonists2025
Bicyclic carboxamides and methods of use thereof2025
Muscarinic acetylcholine M1 receptor antagonists2024
Substituted pyrazoles as type II IRAK inhibitors2024
Bicyclic carboxamides and methods of use thereof2023
Muscarinic acetylcholine M1 receptor antagonists2023
Bicyclic compounds and their use in the treatment of cancer2023
Pyrimidinone derivatives as SHP2 antagonists2023
Carboxamide-pyrimidine derivatives as SHP2 antagonists2023
Triazolone compounds and uses thereof2023
Triazolone compounds and uses thereof2023
Bicyclic compounds and their use in the treatment of cancer2023